Not applicableUnknownNCT06119763What this trial is testingAntiDFS70 Lupus NephritisWho this might be right forSystemic Lupus Erythematosus Sohag University 50
Not applicableNot Yet RecruitingNCT06588192What this trial is testingRenal Survival in Patients with Lupus NephritisWho this might be right forLupus Nephritis (LN) Assiut University 97
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07000292What this trial is testingMSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.Who this might be right forLupus Nephritis (LN)ANCA-Associated Glomerulonephritis Shanghai Changzheng Hospital 12
Large-scale testing (Phase 3)Ended earlyNCT05288855What this trial is testingVoclosporin in Adolescent and Pediatric Subjects With Lupus NephritisWho this might be right forAdolescent Lupus NephritisPediatric Lupus Nephritis Aurinia Pharmaceuticals Inc. 9
Testing effectiveness (Phase 2)Looking for participantsNCT07038382What this trial is testingEvaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active GlomerulonephritisWho this might be right forMembranous NephropathyLupus Nephritis (LN) Shanghai Henlius Biotech 24
Testing effectiveness (Phase 2)Looking for participantsNCT07229742What this trial is testingA Phase II Clinical Study on the Efficacy and Safety of SHR-2173 Injection in the Treatment of Patients With Active Lupus NephritisWho this might be right forActive Lupus Nephritis Guangdong Hengrui Pharmaceutical Co., Ltd 51
Not applicableStudy completedNCT05337124What this trial is testingA Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the USWho this might be right forLupus Nephritis Aurinia Pharmaceuticals Inc. 229
Large-scale testing (Phase 3)Ended earlyNCT00089804What this trial is testingStudy of LJP 394 in Lupus Patients With History of Renal DiseaseWho this might be right forLupus Erythematosus, SystemicLupus Nephritis La Jolla Pharmaceutical Company 943
Large-scale testing (Phase 3)Study completedNCT03597464What this trial is testingAurinia Renal Assessments 2: Aurinia Renal Response in Lupus With VoclosporinWho this might be right forLupus Nephritis Aurinia Pharmaceuticals Inc. 216
Testing effectiveness (Phase 2)Study completedNCT00001789What this trial is testingBG9588 (Anti-CD40L Antibody) to Treat Lupus NephritisWho this might be right forGlomerulonephritis, MembranoproliferativeLupus Nephritis National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 20
Early research (Phase 1)Enrolling By InvitationNCT07038447What this trial is testingKITE-363 in Participants With Refractory Autoimmune DiseasesWho this might be right forSystemic Lupus ErythematosusLupus NephritisSystemic Sclerosis+1 more Kite, A Gilead Company 52
Testing effectiveness (Phase 2)Looking for participantsNCT06947460What this trial is testingCD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAHWho this might be right forRefractory Lupus NephritisSystemic SclerosisPrimary Sjogren's Syndrome Combined With Pulmonary Hypertension Beijing GoBroad Hospital 45
Very early researchLooking for participantsNCT06792799What this trial is testingAnti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune DiseaseWho this might be right forAutoimmune DiseasesSystemic Lupus ErthematosusMulti-Drug Resistant Nephrotic Syndrome+1 more The Children's Hospital of Zhejiang University School of Medicine 36
Not applicableLooking for participantsNCT06682507What this trial is testingHigh Quality Evidence of Guangzhou Lupus Nephritis Cohort (HOPE Cohort)Who this might be right forLupus Nephritis (LN) First Affiliated Hospital, Sun Yat-Sen University 5,000
Testing effectiveness (Phase 2)Study completedNCT04643470What this trial is testingZanubrutinib in Participants With Active Proliferative Lupus NephritisWho this might be right forLupus Nephritis BeiGene 177
Not applicableLooking for participantsNCT06527872What this trial is testingStudy to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LNWho this might be right forLupus Nephritis GlaxoSmithKline 300
Not applicableStudy completedNCT01056237What this trial is testingLong-Term Study of Multi-target Therapy as Maintenance Treatment for Lupus NephritisWho this might be right forLupus Nephritis Zhi-Hong Liu, M.D. 206
Post-approval studies (Phase 4)Study completedNCT01206569What this trial is testingLong-Acting Tacrolimus for the Treatment of Resistant Lupus NephritisWho this might be right forLupus Nephritis Chinese University of Hong Kong 2
Large-scale testing (Phase 3)WithdrawnNCT02074020What this trial is testingCHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without NephritisWho this might be right forSystemic Lupus Erythematosus Anthera Pharmaceuticals
Large-scale testing (Phase 3)UnknownNCT05863936What this trial is testingTrial of Belimumab Combined With Multi-target Induction Therapy in Lupus NephritisWho this might be right forLupus NephritisRemissionSafety Issues Nanjing University School of Medicine 15